ChemicalBook >> CAS DataBase List >>RUFLOXACIN

RUFLOXACIN

CAS No.
101363-10-4
Chemical Name:
RUFLOXACIN
Synonyms
Qari;Mones;Tebraxin;ISF-09334;RUFLOXACIN;4]thiazino[2;AKOS NCG1-0068;3-dihydro-7H-[1;RUFLOXACIN USP/EP/BP;4-ij]quinoline-6-carboxylic acid
CBNumber:
CB1240991
Molecular Formula:
C17H18FN3O3S
Molecular Weight:
363.41
MDL Number:
MFCD00865073
MOL File:
101363-10-4.mol
MSDS File:
SDS
Last updated:2023-05-04 17:34:30

RUFLOXACIN Properties

Boiling point 574.6±50.0 °C(Predicted)
Density 1.54
storage temp. 2-8°C
pka 5.21±0.20(Predicted)
CAS DataBase Reference 101363-10-4
FDA UNII Y521XM2900
ATC code J01MA10

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H335-H302-H315-H319
Precautionary statements  P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P

RUFLOXACIN price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
American Custom Chemicals Corporation API0008750 RUFLOXACIN 95.00% 101363-10-4 250MG $383.25 2021-12-16 Buy
AHH API-1092 Rufloxacin 98% 101363-10-4 5g $760 2021-12-16 Buy
Crysdot CD31004847 Rufloxacin 98+% 101363-10-4 100mg $55 2021-12-16 Buy
Product number Packaging Price Buy
API0008750 250MG $383.25 Buy
API-1092 5g $760 Buy
CD31004847 100mg $55 Buy

RUFLOXACIN Chemical Properties,Uses,Production

Definition

ChEBI: Rufloxacin is a member of quinolines, a quinolone antibiotic and a fluoroquinolone antibiotic.

Pharmaceutical Applications

A tricyclic fluoroquinolone formulated as the hydrochloride salt. It is inactive against Gram-positive cocci with MICs >2 mg/L. It displays weak activity in vitro against Enterobacteriaceae with the MIC for most species >1 mg/L. Activity against Ps. aeruginosa is poor (MIC 16–32 mg/L). After loading doses of 400 and 600 mg followed with 9 days of either 200 or 300 mg, mean peak plasma levels were around 4.5–7 mg/L, respectively. The mean apparent elimination halflife was 44 h. Approximately 50% is eliminated in the urine.
It has been used in urinary tract infection and chronic prostatitis, but clinical experience is limited.

RUFLOXACIN Suppliers

Global( 38)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29220 58
Shanghai Boyle Chemical Co., Ltd. 021-50182298 021-50180596 sales@boylechem.com China 2210 55
Shanghai Fuhe Chemistry Technology Co., Ltd. 0086-21-67651709 cfx759@hotmail.com China 410 57
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 14059 65
Beijing HuaMeiHuLiBiological Chemical 010-56205725 waley188@sohu.com China 12338 58
Chengdu HuaNa Chemicals Co., Ltd. 028-86612776; 13699069380 515238037@qq.com China 963 55
Aikon International Limited 025-66113011 18112977050 sales01@aikonchem.com China 16028 58
Energy Chemical 021-58432009 400-005-6266 marketing1@energy-chemical.com China 44894 58

Related articles

  • Side effects and Uses of Rufloxacin
  • Rufloxacin (MF 934), or 9-fluoro-10-(-methyl) piperazinyl-7-oxo-2,3- dihydro-7H-pyrido-(1,2,3, de) (1,4) benzothiazine-6-carbo....
  • Mar 25,2022

View Lastest Price from RUFLOXACIN manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
RUFLOXACIN USP/EP/BP pictures 2021-07-22 RUFLOXACIN USP/EP/BP
101363-10-4
US $1.10 / g 1g 99.9% 100 Tons min Dideu Industries Group Limited
RUFLOXACIN ISF-09334 AKOS NCG1-0068 8-FLUORO-9-(4-METHYL-PIPERAZIN-1-YL)-6-OXO-2,3-DIHYDRO-6H-1-THIA-3A-AZA-PHENALENE-5-CARBOXYLIC ACID 9-Fluom-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid Mones Qari Tebraxin 9-Fluoro-2,3-dihydro-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid 7H-Pyrido[1,2,3-de]-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo- RUFLOXACIN USP/EP/BP 3-dihydro-7H-[1 4]thiazino[2 4-ij]quinoline-6-carboxylic acid 9-Fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2 101363-10-4 C17H18FN3O3S ACTIVE PHARMACEUTICAL INGREDIENTS